Skip to main content
. 2021 Jan 12;83(3):358–369. doi: 10.1292/jvms.20-0338

Table 2. Detail of double-disk synergy test-positive isolates.

Strain name Year isolated O serogroup Virulence factors β-lactamase Resistance Use of antimicrobial
E2499 2005 UT STa, STb, F4 TEM-1,
CTX-M-15
AMP, PIP, CFZ, CXM, CTX, FEP, ATM, GEN, KAN, STR, TET, CHL, NAL, CIP, LVX, GAT, SXT Unknown

E2525 2006 UT EAST1 TEM-1,
CTX-M-14
AMP, PIP, CFZ, CXM, CTX, FEP, GEN, STR, TET, NAL, CIP, LVX, GAT, SXT Ampicillin, Lincomycin

E2619 2010 34 - CTX-M-24 AMP, PIP, CFZ, CXM, CTX, ATM, STR, TET, CHL, NAL, CIP, LVX, GAT, SXT Not used

E2642 2013 23 - TEM-1,
SHV-12
AMP, PIP, CFZ, CTX, ATM, STR, TET Unknown

E2646 2013 8 EAST1 CTX-M-61 AMP, PIP, CFZ, CXM, CTX, CHL, SXT Ceftiofur, Fluoroquinolone

AMP, ampicillin; PIP, piperacillin; CFZ, cefazolin; CXM, cefuroxime; CTX, cefotaxime; FEP, cefepime; ATM, aztreonam; GEN, gentamicin; KAN, kanamycin; STR, streptomycin; TET, tetracycline; CHL, chloramphenicol; NAL, nalidixic acid; CIP, ciprofloxacin; LVX, levofloxacin; GAT, gatifloxacin; SXT, trimethoprim-sulfamethoxazole.